Anti-EGFR mAb cetuximab therapy increases T cell receptor (TCR) diversity in the peripheral blood and focuses TCR richness in the tumor microenvironment
Benjamin A Kansy, Yan Lin, Fei Ding, Sandra Poveda Gibson, Hyun-Bae Jie, Robert L Ferris
Journal for ImmunoTherapy of Cancer Dec 2015, 3 (Suppl 2) P73; DOI: 10.1186/2051-1426-3-S2-P73
